(c) 2024 PillSync.com

Guaifenesin (guaifenesin 200 mg) Dailymed


Generic: guaifenesin is used for the treatment of Bronchitis Common Cold Cough Laryngitis Pharyngitis Rhinitis, Allergic, Perennial Sinusitis Whooping Cough


IMPRINT: AP 151     SHAPE: round
    COLOR: red

Go PRO for all pill images

Drug Facts


Active Ingredient


(in each immediate-release tablet)

Guaifenesin USP, 200 mg

Purpose


Expectorant

Uses


Helps loosen phlegm(mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings


Ask a doctor before use if you have
  • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
  • cough accompanied by too much phlegm(mucus)

stop use and ask a doctor if cough lasts more than 7 days, comes back, or is accompanied by fever, rash or persistent headache. This could be signs of a serious illness.

If pregnant or breast-feeding, ask a health professional before use.

Keep Out Of Reach Of Children.


In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

  • do not take more than 6 doses in any 24-hour period
  • this product is not intended for use in children under 12 years of age
    adults and children 12 years and over 1 to 2 tablets every 4 hours
    Children under 12 years Do not use

Other Information

  • store at 15-30 °C (59-86 °F)
  • you may report serious side effects to: AvKARE, Inc. at 1 (855) 361-3993 

Inactive Ingredients


Colloidal silicon dioxide, FD&C red #40(Al-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid

Manufactured For: Pulaski, Tn 38478 Mfg. Rev. 04/15 Av 09/16 (p)


Package Label.principal Display Panel


NDC 50268-382-15 Guaifenesin Tablets USP 200mg EXPECTORANT For Ages 12 and Over 50 Tablets (5 x 10) Unit Dose 5026838215

NDC 50268-382-15 Guaifenesin Tablets USP 200mg EXPECTORANT For Ages 12 and Over 50 Tablets (5 x 10) Unit Dose 5026838215

Drug Facts Active ingredient                                       Purpose (in each immediate-release tablet) Guaifenesin USP, 200 mg ...................... Expectorant

Uses helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Drug Facts (continued) Warnings Ask a doctor before use if you have • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema. • cough accompanied by too much phlegm (mucus) Stop use and ask a doctor if cough last more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache. These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Directions • do not take more than 6 doses in any 24-hour period • this product is not intended for use in children under 12 years of age adults and children 12 years and over                1 to 2 tablets every 4 hours children under 12 years                                      do not use

Drug Facts (continued) Other information • store at 15° to 30°C (59° to 86°F). You may report serious side effects to: AvKARE, Inc. at 1 (855) 361-3993 Inactive ingredients colloidal silicon dioxide, FD&C red #40 (Al-lake), magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, stearic acid.

Manufactured for: AvKARE, Inc., Pulaski, TN 38478 Mfg. Rev. 04/15 AV 09/16 (P)

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site